We are live on
!
Find out more
CAN
Claraphi Advisory Network Portfolio holdings
AUM
$251M
1-Year Est. Return
9.29%
This Fund
S&P 500
This Quarter
Est. Return
+25.63%
1 Year Est. Return
-9.29%
3 Year Est. Return
+88.33%
5 Year Est. Return
+135.31%
10 Year Est. Return
–
AUM
$367M
AUM Growth
+$91.1M
(+33%)
Cap. Flow
+$31.7M
Cap. Flow
% of AUM
8.64%
Top 10 Holdings %
Top 10 Hldgs %
46.71%
Holding
314
New
64
Increased
113
Reduced
92
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARK Genomic Revolution ETF
ARKG
|
+$7.95M |
| 2 |
Teladoc Health
TDOC
|
+$2.21M |
| 3 |
QuidelOrtho
QDEL
|
+$2.06M |
| 4 |
ASG
Liberty All-Star Growth Fund
ASG
|
+$1.66M |
| 5 |
LendingTree
TREE
|
+$1.63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Fallen Angel High Yield Bond ETF
ANGL
|
+$3.19M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.19M |
| 3 |
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
|
+$2.41M |
| 4 |
Lowe's Companies
LOW
|
+$1.57M |
| 5 |
AOD
abrdn Total Dynamic Dividend Fund
AOD
|
+$1.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.69% |
| 2 | Technology | 12.95% |
| 3 | Consumer Discretionary | 9.6% |
| 4 | Healthcare | 7.99% |
| 5 | Financials | 4.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Berkshire Hathaway Class B
BRK.B
$1.08T
| $315K | 0.09% |
1,360
+187
| +16% | +$41.2K |
|
202
Generac Holdings
GNRC
$11.1B
| $313K | 0.09% |
+1,375
| New | +$296K |
|
203
Home Depot
HD
$329B
| $312K | 0.09% |
1,175
-14
| -1% | -$3.85K |
|
204
Nike
NKE
$58.6B
| $311K | 0.08% |
2,199
+157
| +8% | +$20.8K |
|
205
Starwood Property Trust
STWD
$5.84B
| $307K | 0.08% |
15,924
+1,023
| +7% | +$17.4K |
|
|
CHI
206
Calamos Convertible Opportunities and Income Fund
CHI
$1.04B
| $306K | 0.08% |
22,568
+1,733
| +8% | +$21.3K |
|
207
NIO
NIO
$10.8B
| $305K | 0.08% |
+6,265
| New | +$242K |
|
208
Rockwell Automation
ROK
$47.9B
| $304K | 0.08% |
1,214
+3
| +0.2% | +$734 |
|
209
Freeport-McMoran
FCX
$109B
| $303K | 0.08% |
+11,645
| New | +$242K |
|
210
Eastman Chemical
EMN
$8.35B
| $302K | 0.08% |
3,010
| – | – |
|
211
Bio-Techne
TECH
$11.4B
| $300K | 0.08% |
3,772
-1,808
| -32% | -$131K |
|
212
Arcturus Therapeutics
ARCT
$428M
| $297K | 0.08% |
+6,845
| New | +$464K |
|
213
Vanguard Total International Bond ETF
BNDX
$82.5B
| $297K | 0.08% |
5,066
-46
| -0.9% | -$2.69K |
|
214
Insperity
NSP
$2.06B
| $297K | 0.08% |
3,651
-589
| -14% | -$48.4K |
|
215
Vanguard FTSE Developed Markets ETF
VEA
$238B
| $297K | 0.08% |
+6,299
| New | +$277K |
|
216
CSX Corp
CSX
$95.1B
| $290K | 0.08% |
+9,579
| New | +$275K |
|
217
Teradyne
TER
$56.1B
| $281K | 0.08% |
+2,348
| New | +$240K |
|
|
FLC
218
Flaherty & Crumrine Total Return Fund
FLC
$173M
| $280K | 0.08% |
11,847
+625
| +6% | +$14.1K |
|
219
Paycom
PAYC
$10.8B
| $277K | 0.08% |
+613
| New | +$244K |
|
220
State Street Health Care Select Sector SPDR ETF
XLV
$44.4B
| $274K | 0.07% |
2,411
-86
| -3% | -$9.39K |
|
221
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.92B
| $272K | 0.07% |
+3,564
| New | +$236K |
|
222
Calamos Strategic Total Return Fund
CSQ
$3.35B
| $272K | 0.07% |
17,215
+1,202
| +8% | +$17.5K |
|
223
Cintas
CTAS
$81.8B
| $270K | 0.07% |
+3,052
| New | +$265K |
|
224
Genmab
GMAB
$20.4B
| $270K | 0.07% |
6,652
-212
| -3% | -$7.92K |
|
|
PARA
225
DELISTED
Paramount Global Class B
PARA
| $268K | 0.07% |
+7,191
| New | +$231K |
|
Similar funds
JW
A
APP
RW
SCM
ACMV
GTCM
CDIA
Claraphi Advisory Network's Q4 2020 Portfolio in Review
As of Q4 2020, Claraphi Advisory Network held 314 positions worth $367M, up 33% from $276M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Claraphi Advisory Network deployed $31.7M of net new capital in Q4 2020, opening 64 new positions and adding to 113 existing holdings. Its largest new stake was Teladoc Health: 10,849 shares worth $2.17M.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 56% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was VanEck Fallen Angel High Yield Bond ETF, an estimated $3.19M trimmed.
- Claraphi Advisory Network's largest Q4 2020 buy was Teladoc Health: 10,849 shares worth $2.17M.
- Claraphi Advisory Network added most to ARK Genomic Revolution ETF in Q4 2020, an estimated $7.95M increase.
- Claraphi Advisory Network's biggest Q4 2020 reduction was VanEck Fallen Angel High Yield Bond ETF, cutting an estimated $3.19M.
- Claraphi Advisory Network fully exited Lowe's Companies in Q4 2020, selling an estimated $1.57M.
- Claraphi Advisory Network's ten largest holdings make up 47% of its $367M portfolio in Q4 2020.
- Claraphi Advisory Network opened 64 new positions and closed 33 in Q4 2020.
- Claraphi Advisory Network's portfolio value rose 33% quarter-over-quarter to $367M.
Based on Claraphi Advisory Network's 13F filing for Q4 2020, filed 5 Feb 2021.